Compugen (CGEN) Tops Q1 EPS by 4c

Compugen (NASDAQ: CGEN) reported Q1 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $496 thousand versus the consensus estimate of $150 thousand.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c